Flexible ureteroscopy: Technological advancements, current indications and outcomes in the treatment of urolithiasis  by Alenezi, Husain & Denstedt, John D.
Asian Journal of Urology (2015) 2, 133e141HOSTED BY Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier .com/locate/ajurREVIEWFlexible ureteroscopy: Technological
advancements, current indications and
outcomes in the treatment of urolithiasis
Husain Alenezi, John D. Denstedt*Division of Urology, Department of Surgery, Schulich School of Medicine & Dentistry, Western
University, London, Ontario, CanadaReceived 3 June 2015; accepted 9 June 2015








Peer review under responsibility o
tion and SMMU.
http://dx.doi.org/10.1016/j.ajur.2015
2214-3882/ª 2015 Editorial Office of A
article under the CC BY-NC-ND licenseAbstract The last 3 decades have witnessed great improvements in the technology and clin-
ical applications of many minimally invasive procedures in the urological field. Flexible ure-
teroscopy (fURS) has advanced considerably to become a widely utilized diagnostic and
therapeutic tool for multiple upper urinary tract pathologies. The most common indication
for fURS is the treatment of upper urinary tract stones with the aid of Holmium:Yttrium
Aluminium Garnet (YAG) laser lithotripsy. Advancements in endoscope technologies and oper-
ative techniques have lead to a broader application of fURS in the management of urolithiasis
to include larger and more complex stones. fURS has proved to be an effective and safe pro-
cedure with few contraindications. Continued progression in fURS may increase its clinical
applicability and supplant other procedures as the first line treatment option for urolithiasis.
ª 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Flexible ureteroscopy (fURS) has been through significant
technological and technical advancements in the previous
3 decades, resulting in the widespread utilization of fURS in@sjhc.london.on.ca (J.D.
f Shanghai Medical Associa-
.06.002
sian Journal of Urology. Productio
(http://creativecommons.org/lithe treatment of a variety of upper urinary tract pathol-
ogies, mainly urolithiasis.
Herein, we discuss the major technologic advances in
fURS, its current role and outcomes in the treatment of
urolithiasis.
2. History and technological advancements of
fURS
Since the first report of fURS by Marshall in 1964 [1], major
developmental milestones in the technology of flexiblen and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
censes/by-nc-nd/4.0/).
134 H. Alenezi, J.D. Denstedtureteroscopes have led to the current relative ease of
clinical application together with a high success rate and
low associated morbidity. In 1980’s, fURS was significantly
improved after the development of fiberotic light-bundles
together with endoscope tip-deflection mechanisms (pas-
sive or active) and the incorporation of an irrigation
working-channel that allowed its use as a therapeutic tool
[2]. The next substantial technological advancement was in
1994, after the successful therapeutic utilization of a
miniaturized flexible ureteroscope, with a tip diameter of
7.5 Fr and an adequate working-channel of 3.6 Fr [3]. The
miniaturized flexible ureteroscope enabled active 2-way
deflection with secondary passive deflection at the shaft,
thus increasing endoscope maneuverability and clinical
applicability.
Concurrently, the successful introduction of the Hol-
mium:Yttrium Aluminium Garnet (YAG) laser as a flexible
intracorporeal lithotripter with a high safety margin lead to
an increased interest in the treatment of urolithiasis in a
retrograde fashion [4]. In 2001, a flexible ureteroscope with
active 2-way exaggerated deflection (up to 270) was
introduced to the market and improved the ability to
navigate the entire pelvicaliceal system [5]. The durability
of flexible endoscopes subsequently improved and it
became possible to perform up to 50 therapeutic pro-
cedures before any maintenance was necessary [6]. The
revolution of endoscope technology continued with the
introduction of digital flexible ureteroscopes in 2006, which
improved the image quality and resulted in lighter-weight
equipment due to the integration of the light-cable and
camera within the endoscope. Unfortunately, digital flex-
ible ureteroscopes had a larger diameter than the con-
ventional fiberoptic flexible counterparts and their use was
associated with increased need for placement of a ureteral
access sheath (UAS) [7], which is associated with higher risk
of ureteral injuries [8]. However, further development led
to the introduction of smaller caliber digital flexible ure-
teroscopes comparable to the previous conventional en-
doscopes [9].
Advancements and innovations in technology have
continued to progress with the goal of designing optimal
small diameter endoscopes, improved image quality and
maneuvering abilities combined with lasting durability. In
2010, Sun et al. [10] reported the first combined rigid and
flexible ureteroscope “the Sun’s ureteroscope”. The au-
thors treated 175 patients with intrarenal stones using this
novel ureteroscope, which has a retractable rigid shaft and
flexible tip that enables the operator to treat ureteral and
intrarenal stones efficiently without the need to exchange
from one endoscope to another. The Sun’s ureteroscope
resulted in short operative time with an overall stone-free
rate (SFR) of 83%. In 2008, Desai et al. [11] reported their
feasibility study using a new innovative robotic flexible
ureteroscope in an animal model, that was followed by a
report on their encouraging clinical experience in treating
urolithiasis using the same robotic flexible device [12]. In
2014 the initial experience with a new robotic platform for
fURS was reported [13]. Seven experienced surgeons
examined the new robotic platform in treating 81 patients
with urolithiasis. The initial experience was successful and
was associated with improved ergonomics in comparison to
conventional counterparts.3. The current role of fURS in the treatment of
urolithiasis
3.1. Treatment of intrarenal stones less than 2 cm
With the continued advancements of technology and
increasing experience gained by urologists in ureteroscopic
skills, fURS has become an integral aspect of the arma-
mentarium in treating intrarenal stones less than 2 cm in
diameter. In the previous iteration of the European guide-
lines on the management of urolithiasis, fURS was recom-
mended as a second-line treatment for stones less than
2 cm after shock wave lithotripsy (SWL), however in the
recent revision of the guidelines, both fURS and SWL were
recommended as first-line management options especially
for stones measuring between 11 and 20 mm [14], reflecting
the increasing success in treating intrarenal stones in a
retrograde fashion.
In 1990’s, the initial reports on successful management
of urolithiasis with fURS came from high-volume experi-
enced centers [15,16]. Grasso and Ficazzola [16] achieved
an SFR of 94% and 95% for intrarenal stones measuring less
than or equal to 10 mm and 11e20 mm, respectively with
fURS and laser lithotripsy. Sofer et al. [15] reported their
experience with a large cohort of patients including 598
patients who were treated with ureteroscopy (URS) and
laser lithotripsy from 1993 till 1999. The average stone size
was 11.3 mm and 56 of the included patients had intrarenal
stones treated with fURS. The authors achieved an SFR of
84% for intrarenal stones with a low overall complication
rate of 4%.
Comparative studies of fURS, SWL and/or percutaneous
nephrolithotripsy (PCNL) showed an advantage in the suc-
cess rate of fURS over SWL [17], while fURS had a compa-
rable success-rate to PCNL (or Miniperc) with lower
associated morbidity in the treatment of intrarenal stones
[18e20].
It is anticipated that fURS will play a more important
role in the management of symptomatic intrarenal stones in
the near future and fURS may significantly supplant SWL as
the modality of choice for treating intrarenal stones less
than 2 cm.
3.2. Treatment of intrarenal stones greater than
2 cm
PCNL is the gold standard for large renal stones measuring
2 cm or greater as defined by American Urological Associ-
ation (AUA) and European Urological Association (EUA)
guidelines [14,21]. PCNL however can be associated with
significant complications, longer hospital stay and conva-
lescence. Therefore, a less morbid option to treat large
renal stones would be especially advantageous to high-risk
patients.
Early reports on the use of fURS in the treatment of
large renal stones appeared in the 1990’s, when Aso et al.
[22] described their experience in treating 34 patients with
staghorn renal stones. At that time, the only available
flexible intracorporeal lithotripter was electrohydraulic
based, which resulted in a high complication rate rendering
fURS an unacceptable management option for large renal
Technological advancements in the treatment of urolithiasis 135stones. Efforts to find a safe alternative to PCNL continued
and a trial to combine fURS with SWL to treat staghorn
stones was successful in fragmenting 21 out of 27 stones
[23], patients however required up to 26 SWL sessions
(mean of 8.4 procedures), leading to concerns about shock
wave bioeffects on the renal parenchyma and costs. With
further advancement of endoscope and Holmium:YAG laser
lithotripter technology, fURS has re-emerged as a thera-
peutic option for large renal stones. Grasso et al. [24]
treated 45 large intrarenal stones using fURS and Holmiu-
m:YAG laser lithotripsy. They included patients with stones
greater than 2 cm in a population with medical comor-
bidities that precluded treatment with PCNL. The SFR,
defined as fragments less than 2 mm, was encouraging at
76% after the first treatment and re-treatment with fURS
increased the final SFR to 91%. The high success rate
reported by Grasso et al. [24] was accompanied by a low
postoperative complication rate of 6.2%. Recently, a meta-
analysis by Aboumarzouk et al. [25] included nine primary
studies reporting on 445 patients (460 renal units) diag-
nosed with large intrarenal stones and treated with fURS
and laser lithotripsy. The average SFR was 93.7% (range
77.0%e96.7%) after an average of 1.6 procedures per pa-
tient for treatment stones with of a mean size of 2.5 cm.
That high success rate, comparable to PCNL results, was
associated with a complication rate of 10.1%. Major com-
plications including steinstrasse, subcapsular hematoma,
obstructive pyelonephritis, cerebrovascular accident,
acute prostatitis and hematuria leading to clot retention
were noted in 5.3% patients, while 4.8% of patients expe-
rienced minor complications mostly self limiting hematuria
and postoperative fever. However, a subgroup analysis
revealed no major complications in the group of patients
with a 2e3 cm stone. Further reports on fURS for the
treatment of large renal stones achieved similar high SFR
after multiple procedures [26,27]. Concurrent use of UAS,
which facilitated multiple re-entries of the endoscope and
improved visibility, was noted as a factor contributing to
improved outcomes.
Akman et al. [28] pair-matched and analyzed 34 patients
with 2e4 cm renal stones treated with fURS with patients
treated with PCNL. Patients were matched on de-
mographics (age, gender and body mass index), renal
anomalies (solitary kidney and degree of hydronephrosis),
stone characteristics (size, number and location) and his-
tory of previous interventions (SWL and open surgery). The
initial stone-free status was significantly higher in favor of
PCNL (73.5% and 91.2% for fURS and PCNL, respectively),
but the difference lost its significance after the second
fURS procedures with a final SFR of 88.2%. PCNL was found
to be statistically better in terms of shorter mean operative
time, but with a longer hospital stay than fURS. There was
no statistical difference in the associated complications
after both procedures, although two patients required
blood transfusions after PCNL. However, fURS was found to
be significantly inferior in treating intrarenal stones greater
than 2 cm compared to miniperc (18 Fr tract) in another
matched-pair analysis [29]. The success rate was only 43.4%
after the first fURS procedure.
In most series, the number of procedures required to
achieve a successful outcome is the main concern in using
fURS to treat large intrarenal stones [30]. This is offset bythe low associated complication rate, making fURS a valid
alternative to PCNL especially in high-risk patients.
fURS has also been described as a successful adjunct to
PCNL in treating complex renal stones in order to reduce
the number of tracts and associated complications [31e34].
fURS was performed either simultaneously with or in a
staged fashion from PCNL resulting in results equal to
conventional PCNL.
3.3. Treatment of lower pole stones
Treatment of lower pole renal stones is an ongoing dilemma
due to the dependent position of the lower calyces limiting
spontaneous passage of stone fragments after SWL [35].
Additionally, the anatomy of the lower pole calices makes
them less accessible by flexible ureteroscopes than mid or
upper calices. In 1999, Grasso and Ficazzola [16] failed to
access the lower pole by fURS in 7% of their patients using
an early generation ureteroscope with limited active
deflection ability, yet they achieved a high success rate in
treating 93% of the cohort with an SFR of 94% and 95% for
stones greater than 1 cm and less than 1 cm, respectively.
Researchers have tried to determine the anatomical factors
associated with failure to access the lower pole in a
retrograde fashion by fURS [36e38]. An acute infundibulo-
pelvic angle (<30) and a long infundibular length (>3 cm)
were found to be associated with lower SFR in treating
lower calyceal stones, while there was no effect exerted by
the infundibular width [36e38]. However, after the devel-
opment of modern endoscopes with extended active
deflection abilities and advancement of operative tech-
niques [39], accessibility of lower pole stones to fURS has
improved. Stone repositioning to a more accessible calyx
using tipless Nitinol baskets before laser lithotripsy is a
technique that has improved the success rate of fURS in
treating lower pole stones. Baskets result in minimal loss of
endoscope active deflection and irrigation flow in compar-
ison to the smallest laser fiber facilitating successful access
to the lower pole with better visibility [40]. Schuster et al.
[41] found an improved SFR after stone repositioning in
comparison to in situ lithotripsy of lower pole stones. The
difference was significant especially for stones greater than
1 cm, with SFR of 100% and 29% for stone repositioning and
in situ lithotripsy, respectively. As a result of technological
and technical advancements, some authors have demon-
strated equivalent SFR achieved after treating lower pole
stones compared to stones residing in other calyces with
fURS [42,43].
Although fURS had no advantage over SWL in treating
lower pole stones 1 cm in a randomized control trial
conducted by the Lower Pole Study Group [44]. More recent
studies have demonstrated advantages in favor of fURS
[45,46]. In 2012, El-Nahas and colleagues [45] analyzed a
matched-pair group of patients with 10e20 mm lower pole
stones treated with fURS or SWL. fURS had a statistically
significant higher SFR (86.5% vs. 67.7% for SWL) and lower
retreatment rate (8% vs. 60% for SWL group). A recent
prospective randomized trial by Kumar et al. [46] included
195 patients with radio-opaque lower pole stones treated
by fURS or SWL. The mean stone size was comparable in the
two groups (12 mm). Both treatment groups had compara-
ble SFR at 3 months, but the retreatment rate was
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fURS). The additional retreatment rate would impact the
associated costs of both procedures.
fURS was also retrospectively compared to PCNL (and
miniperc) in the treatment of lower pole stones less than
20 mm [47,48]. The success rate was similar in both groups
with no difference in associated complications. PCNL and
miniperc were associated with shorter operative time,
higher fluoroscopy time and longer hospital stay in com-
parison to fURS.
fURS seems poised to play an important role in the
management of lower pole renal stones less than 2 cm.
3.4. Proximal ureteral stones
SWL and fURS account for the vast majority of interventions
for proximal ureteral stones worldwide. Both procedures
are accepted as first line treatment option for proximal
ureteral stones according to the latest EAU guidelines [14].
Although a less invasive procedure than fURS, SWL has been
associated with a lower success rate and higher retreat-
ment rate in comparison to fURS for ureteral stones [49].
Additionally, Pace et al. [50] demonstrated a significant
decrease in the SFR with retreatment of ureteral stones by
SWL after a failed initial treatment. On the other hand,
early reports on fURS and laser lithotripsy for the treatment
proximal ureteral stones demonstrated a high SFR of more
than 95% [15,24]. The high success rate of fURS in treat-
ment of proximal ureteral stones was recently re-
demonstrated in a prospective, multi-institutional study
that included 71 patients with solitary proximal ureteral
stones [51], with an overall SFR of 95% and SFR of 100% for
stones less than 1 cm. In a systematic review by Kijvikai
et al. [52] to examine the outcomes of SWL and URS in the
management of proximal ureteral stones less than or equal
to 2 cm, a significantly better outcome was found after URS
for stones over 10 mm. However, the review included het-
erogeneous data from studies of both semi-rigid URS and
fURS.
Therefore, fURS may be considered a competitive option
to treat proximal ureteral stones when compared to SWL,
especially in treating larger stone burdens or SWL-refractory
stones.
4. Stones in special situations
4.1. Treatment of urolithiasis during pregnancy
Despite the low incidence of urolithiasis during pregnancy,
it is the most common non-obstetric cause for hospital
admission [53]. In a population-based retrospective cohort
study, Swartz et al. [54] found that pregnant women
admitted to hospital with urolithiasis have an increased risk
of preterm delivery in comparison to pregnant women
admitted due to other non-obstetric causes. There was no
significant difference in obstetric complications between
pregnant patients who underwent intervention for neph-
rolithiasis compared to patients who did not [54].
Up to 20% of pregnant women with nephrolithiasis may
require procedural intervention [53]. Temporizing mea-
sures with deferred definitive treatment have a limited rolein the management of urolithiasis during pregnancy, espe-
cially during the first two trimesters, due to the associated
increased encrustation of ureteric stents and blockage of
nephrostomy tubes with subsequent need for frequent ex-
changes [55]. Additionally, SWL is contraindicated during
pregnancy due to potential harmful effects on the devel-
oping fetus [14]. Thus, URS poised to be an attractive
definitive option to treat urolithiasis during pregnancy [56].
In 1988, Rittenberg and Bagley [57] were the first to
report performing fURS in two pregnant women. Watterson
et al. [58] treated eight pregnant women with urolithiasis
by URS (semi-rigid and flexible) using the Holmium:YAG
laser under general anesthesia and achieved an 89% SFR
with no postoperative urologic or obstetric complications.
Ureteral dilatation was not required in their series, how-
ever six patients had pre-stented ureters [58]. While Lif-
shitz and Lingeman [59] had to dilate the ureteric orifices in
four patients to facilitate URS, they performed fURS in the
majority of patients under spinal anesthesia with no major
postoperative complications.
Semins et al. [60] performed a systematic review
examining the safety of URS during pregnancy. The authors
found a low rate of postoperative complications in 108
patients. Most of the reported complications were Clavien
level 1 and 2, and there was no significant difference in
ureteral injury or urinary tract infection rates in compari-
son to a multinational meta-analysis of URS in non-pregnant
women.
Although large cohort studies are not available in the
literature, fURS seems to be a safe definitive method for
treatment of urolithiasis during pregnancy with a low rate
of major complications.
4.2. Treatment of urolithiasis in children
In the recent years, the vast majority of pediatric urolithiasis
are managed by minimally invasive endourologic procedures
such as SWL, URS and PCNL [61]. Similar to the adult popu-
lation, the shift from open surgery to endourologic man-
agement was possible due to advancement of technology
and miniaturization of endourologic instruments. Previously,
concerns over instrument associated intraoperative compli-
cations such as ureteral perforation and vesicoureteral reflux
lead to the late adoption of URS in the treatment of pedi-
atric stone disease. While currently, URS (both semi-rigid
and flexible) is playing an important role in the management
of upper urinary tract stones in children and is now feasible
even in preschool age children [62].
Tan et al. [63] published one of the first reports on the
management of pediatric urolithiasis by URS that included
six children who were treated by fURS successfully. In
2008, Kim et al. [64] had the largest cohort of pediatric
patients treated by fURS and Holmium:YAG laser litho-
tripsy. The authors performed 170 procedures to treat 167
children suffering from intrarenal and ureteral stones,
with 100% and 97% stone clearance for stones less than
10 mm and greater than 10 mm, respectively. The mean
age of their patients was 62.4 months with a mean stone
size of 6.12 mm (range 3e24 mm). Active ureteral dilation
was avoided, but initial retrograde access was not possible
in 57% of the children who were subsequently stented for
1e2 weeks followed by successful fURS. The authors
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complications were encountered with a mean follow-up of
19.7 months. Likewise, fURS with laser lithotripsy was
found to be a safe and effective procedure in treating
pediatric intrarenal stones by a systematic review that
included 282 children from six studies [65]. With a total
reported complication rate of 12.4%, the vast majority of
the complications were within Clavien grade 1 or 2. Only
six patients had Clavien grade 3 complications; five ure-
teral perforations and one extravasation, which were
related to UAS insertion or active balloon dilatation of the
ureter [62,66]. The mean SFR reported in the systematic
review was 85.5% (range 58%e93%) after one fURS proce-
dure, demonstrating the effectiveness of fURS in children.
Despite the apparent need for pre-stenting in a signifi-
cant percentage of children prior to achieving safe retro-
grade ureteroscopic access, Mokhless et al. [67] were able
to proceed with initial URS in almost all of the included
children by starting with the semi-rigid ureteroscope to
hydro-dilate the ureter before inserting the flexible ure-
teroscope. They prospectively compared the outcomes of
retrograde intrarenal surgery (RIRS) to SWL in the treat-
ment of pediatric renal stones after randomly allocating 60
children (mean age of 2.4 years) with 10e20 mm stones into
one of the two treatment arms. RIRS was found to have a
better initial SFR of 86.6% in comparison to 70% after SWL,
however at 3 months the SFR was comparable at 96.6% and
93.3% post RIRS and SWL, respectively. Furthermore, in a
multi-center comparative analysis of the outcomes of pe-
diatric patients with renal stones 10e30 mm in size treated
with miniperc (n Z 106) or RIRS (n Z 95) [68], stone-free
status was comparable at 84% and 86% for RIRS and mini-
perc, respectively. However, minor complication rates
were 8.4% for RIRS and 17% for miniperc, with 6% trans-
fusion rate after miniperc in comparison to no blood
transfusion post RIRS. Moreover, the analysis showed
favorable results to RIRS in terms of shorter fluoroscopy
exposure, operative time and hospital stay, compared to
miniperc.
4.3. Treatment of urolithiasis with renal anomalies
The management of urolithiasis in patients with anomalous
kidneys imparts a special challenge to the treating urologist
[69], due to the associated abnormal vascular supply, pel-
vicaliceal anatomic abnormalities such as ureteropelvic
obstruction, and the unusual relation to surrounding
structures.
SWL has a high failure rate in patients with renal
anomalies due to either the impaired urinary drainage
associated with the anomaly or difficulty targeting the
stone due to overlying bones [69]. More invasive procedures
such as PCNL and laparoscopy can be associated with
increased risk of iatrogenic injury to adjacent organs and
vascular structures [69]. Thus, fURS offers a minimally
invasive therapeutic option for urolithiasis in patients with
renal anomalies that can be performed as a day-procedure
with low rate of complications.
Horseshoe kidney (HSK) is one of the common renal
anomalies with an incidence up to 1/400 live births and is
associated with urolithiasis in 20% of the cases [70]. Weizer
et al. [71] were the first to report the successful treatmentof renal stones in patients with HSK with fURS. They ach-
ieved a 75% SFR after performing fURS with Holmium:YAG
laser lithotripsy and nitinol baskets in four patients with
HSK and four patients with pelvic ectopic kidneys (PEK). In
2010, Molimard and colleagues [72] published their retro-
spective experience in treating 17 HSK patients with fURS
and laser lithotripsy. Of the 17 included patients, eight had
SWL refractory stones and four patients failed previous
PCNL. Stone repositioning was required in nine patients
with lower pole stones before laser lithotripsy. Their re-
ported success rate, defined as stone-free status or residual
stone less than 3 mm, was 88.2% after 1.5 procedures for
the treatment of stones measuring 7e35 mm (average of
16 mm), with no major complications encountered. More
recently, the Turkish experience was reported in treating
20 patients with a mean stone size of 17.8 mm in HSK by
fURS [70]. Treatment was successful in 70% of patients who
were rendered either completely stone free or with insig-
nificant residual fragments less than 4 mm. Postoperative
complication rate of 25% consisted of only minor Clavien
grade 1 and 2 complications that included fever and self-
limiting hematuria.
While Weizer et al. [71] had a 75% success rate in
treating intrarenal stones within 4 PEK patients by fURS,
Bozkurt et al. [73] experienced 84.6% successful fURS pro-
cedures in their retrospective multi-center report of 26
patients with stone bearing PEK. The mean stone size was
17 mm (range of 10e28 mm) with nine SWL refractory
stones. Stone lithotripsy was accomplished by Holmiu-
m:YAG laser lithotripsy while stone repositioning was per-
formed only if needed. The authors reported 19.2%
postoperative complication rate with two patients requiring
insertion of ureteral stents due to persistent renal colic.
The role of fURS and laser lithotripsy in the treatment of
stone bearing calyceal diverticula was perhaps more stud-
ied than other pelvicaliceal system anomalies. In 2010,
Sejiny et al. [74] reported the largest retrospective cohort
at that time describing their experience in treating symp-
tomatic stone bearing calyceal diverticula with fURS and
laser lithotripsy. They treated 36 symptomatic patients
with an average stone size of 11.4 mm (5e22 mm), with 30
stones that had failed previous SWL. In that report, the
authors described “The blue-test”, a novel technique to
identify the diverticular neck in difficult cases using
retrograde Methylene blue injection. After identification of
the diverticular neck, careful incision of the neck was
carried out to allow the passage of the flexible uretero-
scope into the diverticulum. Neck incision was performed in
30 patients using high frequency and low energy laser set-
tings (10 Hz and 0.8 J). The authors achieved 55.3% SFR
with an additional 26.3% of patients having insignificant
residual fragments less than 4 mm. Ninety percent of pa-
tients were rendered symptom-free making the results
comparable to those after PCNL in treating calyceal diver-
ticula stones, yet with lower morbidity, as there were no
major complications observed after the fURS. Koopman and
Fuchs [75] successfully identified the neck or the stenotic
infundibular segment in 95% of 108 symptomatic patients
due to intrarenal stones residing in caliceal diverticula or
beyond an infundibular stenosis. They were able to dilate
or incise the stenotic segment in 94% of the patients after
successfully coiling a guide-wire into the diverticulum or
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were used in patients with less than 2 cm stones, while
patients with stones 2 cm and larger were treated using a
combined approach of fURS, laser lithotripsy with nitinol
baskets and SWL. The SFR was 90% and 75% for stones less
than 2 cm and 2 cm and greater, respectively. Both Sejiny
et al. [74] and Koopman and Fuchs [75] noticed greater
difficulty and less satisfactory results associated with lower
pole stones in comparison to other calyces.
4.4. Treatment of urolithiasis in anticoagulated
patients
Patients with bleeding diathesis or on anticoagulation
medications cannot be treated with PCNL or SWL due to the
associated risk of significant bleeding. While fURS has been
proven to be safe and efficient when used together with the
Holmium:YAG laser lithotripsy in the treatment of urolith-
iasis in patients with different types of bleeding diatheses
or anticoagulants [76e79]. Watterson et al. [76] reviewed
the charts of 25 patients with bleeding diathesis who were
managed by ureteroscopic procedures for the treatment of
urolithiasis. The bleeding diathesis consisted of warfarin
administration in 17 patients, thrombocytopenia in four,
liver end-stage disease in three and von Willebrand’s dis-
ease in one. Ninteen procedures were performed mainly
using fURS and the Holmium:YAG laser lithotripsy, while
electrohydraulic lithotripsy was used earlier in the study in
two patients. The authors found only one major complica-
tion, retroperitoneal bleeding, in a patient who was
concomitantly treated by electrohydraulic lithotripsy while
there was no complications in the rest of the patients
treated with the aid of the Holmium:YAG laser lithotripsy.
More recently, a pair-matched analysis was performed by
Turna et al. [78] to examine the safety of fURS and Hol-
mium:YAG laser lithotripsy in treating intrarenal stones in
anticoagulated patients. Although the anticoagulation
group was significantly older and had a greater American
Society of Anesthesiologists Score, there was no difference
in the intraoperative and postoperative complications with
comparable SFR rates.
4.5. Treatment of urolithiasis in obese patients
Obesity is a common prevalent disease of the Western
world that is associated with higher risk of urolithiasis. Yet
obesity can negatively affect the treatment options for
upper tract urinary stones. The success rate of SWL is
decreased with obesity and greater skin-stone distance,
while PCNL becomes more complicated in obese patients
due to the longer tracts and increased risk of anesthetic
complications associated with prone positioning. The effi-
cacy of fURS in the treatment of upper tract stones in obese
and morbidly obese patients has been well studied [80e86],
and the SFR and associated complications of fURS were not
affected by the patient’s body mass index [84e86].
5. Contraindications and complications of fURS
Apart from general considerations, such as anesthetic
contraindications and untreated urinary tract infection,fURS has no specific contraindication [14]. fURS can be
performed in virtually every patient and it is especially
suitable in situations when PCNL and SWL are either con-
traindicated or unsuitable.
The continually developing endoscope technology and
the associated widespread utilization of fURS [87] have led
to increased experience and improved skills in performing
the procedure with low associated morbidity [88]. In the
prospective CROES study, which included 11,885 patients
from 114 centers in 32 different countries, 15% of the
included patients (n Z 1781) underwent fURS alone, while
another 10.7% had combined semirigid and fURS for the
treatment of their stones [89]. The overall postoperative
complication rate was as low as 3.5% and the majority of
the complications were Clavien grade 1 or 2 (2.8%). Only
0.2% of patients required blood transfusion, and there were
five mortalities in the 30-day postoperative period due to
sepsis, lung embolism, multi-organ dysfunction and cardiac
causes. The readmission rate in the CROES URS study was
8.4% at 3 months postoperatively mainly due to flank pain
and ureteral stent discomfort. In a subgroup analysis re-
ported separately, there was no significant difference
observed for postoperative complications or readmission
rates between semirigid and fURS [90].
6. Conclusion
The role of fURS in the management of urolithiasis has
expanded greatly during the last 3 decades thanks to the
advancing equipment technology and surgical techniques.
Increased ureteroscopic skills and experience together with
miniaturization of flexible ureteroscopes has lead to an
associated high safety margin for fURS. fURS is expected to
play a more important role in the management of urolith-
iasis in the near future.Conflicts of interest
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